Clary Strategies retweeted
We are seeking your input on our policy priorities. Please complete this short, six-question survey to help us identify what matters to you most! alf.social/ADV25WB
The patient program grows and grows each year. Thank you @AASLDtweets for your commitment to including the patient and patient advocate experience. #TLM24
Kicking off our Patient Program with more than 160 patients, advocates and caregivers in person and more following online via TLMdX. #TLM24
1
134
Clary Strategies retweeted
Keynote speaker, Ahmad Anouti, MD, suffered from liver disease from birth, had a liver transplant as a teenager, completed medical school and is now focused on research and patient advocacy. He is a symbol of hope to families around the world. #TLM24
I’m looking forward to my first in person Liver Meeting since 2019, seeing old friends and colleagues, and catching up on the latest efforts to eliminate HBV and HCV. #TLM24
Clary Strategies retweeted
California youth are experiencing an alarming rate of STIs. Young people make up more than 5 out of every 10 chlamydia cases in CA, and more than 87% are youth of color. @GavinNewsom must sign #SB954 into law! #YHES4Condoms
California spends approximately $1 billion annually on health costs associated with STIs. Implementing free condoms in high schools is a cost-effective strategy to help curb the state’s public health crisis. I urge @GavinNewsom to sign #SB954! #YHES4Condoms @EssnAccessHlth
Clary Strategies retweeted
ETE press release: Victory - expansion of HIV services drive.google.com/file/d/1Z0n…
Clary Strategies retweeted
Please join @HIVHep & @AIDSUnited for a webinar on July 11, 4-5pm EDT, to help prepare for @MedicarePartB’s new coverage of #PrEP w/@WhiteHouse #AIDS Director Francisco Ruiz & @CMSGov’s Dora Hughes, with a panel of experts. Register here: bit.ly/3RFblGq
Clary Strategies retweeted
Viral #Hepatitis impacts millions of individuals in the US.
Read the National Viral Hepatitis Progress Report to learn how @CDCgov and our partners are doing the crucial work of addressing the burden of viral hepatitis: bit.ly/4cCRXTv

ALT Bar chart shows observed HCV infections vs. annual targets, from 2017 to 2022. Text reads: "Despite decreasing for the first time after a decade of consecutive annual increases, the number of estimated new hepatitis C virus (HCV) infections in 2022 was 67,000 - well above the annual target of 36,617."
Clary Strategies retweeted
Join us tomorrow for our webinar - "Approaching and Supporting LGBTQ Patients: Practical Tips for Clinicians." Register now: aasld.org/webinar-approachin…
ICYMI - @RepHankJohnson @NydiaVelazquez release Dear Colleague calling for expanded access to #hepb vaccines in Medicare. @hepatitismag @KFF @NASTAD @NVHR1 @AIDSInstitute @AAPCHOadvocates @AASLDtweets @pharmacists hankjohnson.house.gov/media-…
ICYMI @hepatitismag
2
20
I haven’t been with NVHR in years but I’m proud of this article and glad @hepatitismag circulates it from time to time.
#HepStories Ryan Clary has played a major part in shaping the national conversation around viral hepatitis. hepmag.com/article/ryan-clar…
1
44
Thank you @EleanorNorton for your support for hepatitis B vaccine access!
hankjohnson.house.gov/media-…
2
22
Thank you @RepAdams for supporting access to hepatitis B vaccines!
hankjohnson.house.gov/media-…
1
22
Thank you @RepBarbaraLee for supporting access to Hep B vaccines!
hankjohnson.house.gov/media-…
Thank you @RepSwalwell for supporting access to Hep B vaccines! hankjohnson.house.gov/media-…
Clary Strategies retweeted
Proud to co-lead this effort with @RepHankJohnson to increase access to hepatitis B vaccines for seniors!
I co-led a letter recommending @CMSGov take steps to facilitate enhanced beneficiary access to HBV vaccines - which would not only result in prevention of infections & associated cost savings, but allow those on Medicare to be reimbursed for HBV vaccines w/out a physician order.
Thank you for your leadership! @hepatitismag
I co-led a letter recommending @CMSGov take steps to facilitate enhanced beneficiary access to HBV vaccines - which would not only result in prevention of infections & associated cost savings, but allow those on Medicare to be reimbursed for HBV vaccines w/out a physician order.

























